H E X A L AG has a total of 13 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2009. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and China. Its main competitors in its focus markets pharmaceuticals and medical technology are EURODRUG LAB B V, JAY PHARMA INC and ZHENGZHOU SAIKE PHARMACEUTICAL TECH CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | China | 1 | |
#4 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Medical purpose containers |
# | Name | Total Patents |
---|---|---|
#1 | Krekeler Andreas | 5 |
#2 | Kohr Thomas | 5 |
#3 | Wawra Christian | 3 |
#4 | Wolf Claudia | 3 |
#5 | Neumann Dimitri | 3 |
#6 | Marchesan Marco | 3 |
#7 | Sedlmayr Michael | 2 |
#8 | Krekeler Andreas Dr | 1 |
#9 | Marchesan Marco Dr | 1 |
#10 | Oppelt Renate | 1 |
Publication | Filing date | Title |
---|---|---|
EP3335699A1 | Selexipag formulation in liquisolid system | |
EP3275432A1 | Dosage form with ace inhibitor | |
CN107810005A | Egelieting preparation | |
EP2255794A1 | Enteric coating |